Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor
Open Access
- 22 March 2024
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 26 (6) , 479-486
Abstract
No abstract availableKeywords
Funding Information
- MSD Sharp and Dohme
- Takeda Pharmaceutical Company
This publication has 23 references indexed in Scilit:
- Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)Translational Oncology, 2023
- Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)npj Precision Oncology, 2022
- Quantitative Off-Target Detection of Epstein-Barr Virus–Derived DNA in Routine Molecular Profiling of Hematopoietic Neoplasms by Panel-Based Hybrid-Capture Next-Generation SequencingThe Journal of Molecular Diagnostics, 2022
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 studyThe Lancet Oncology, 2020
- Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyJournal of Thoracic Oncology, 2020
- Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trialThe Lancet Oncology, 2020
- Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical ArtifactsJournal of Thoracic Oncology, 2019
- Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancernpj Breast Cancer, 2018
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Targeting the DNA damage response for cancer therapyDNA Repair, 2009